Method for the treatment of topical inflammatory diseases

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514825, 514886, A61K 910, A61K 906, A61K 3578

Patent

active

059685190

ABSTRACT:
Method for the treatment of inflammation and pain associated with inflammatory dermatoses, gingivitis and acute injury with a composition of finely divided powder of safflower seed or its extract contained in a pharmaceutically acceptable carrier.

REFERENCES:
patent: 2978381 (1961-04-01), Freedman et al.
patent: 3584129 (1971-06-01), Kitson
patent: 4009290 (1977-02-01), Okumari et al.
patent: 4072669 (1978-02-01), Betschart
patent: 4623539 (1986-11-01), Tunc
patent: 4806354 (1989-02-01), Green
patent: 4898721 (1990-02-01), Alvey
patent: 4981844 (1991-01-01), Alexander et al.
patent: 5063062 (1991-11-01), Greenspan et al.
patent: 5162113 (1992-11-01), Oh et al.
patent: 5397778 (1995-03-01), Forse et al.
patent: 5436386 (1995-07-01), Weisker
patent: 5753266 (1998-05-01), Youssefyeh et al.
C.A. 128: 200726 R.B. Zurier et al Arthritis Rheum. 41(1) 1998 163-170.
C. A. 129:280984 C. Hioki et al Sep. 8, 1998.
C. A. 95:171434 May 26, 1981 Nihon Surfactants Co. Ltd.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the treatment of topical inflammatory diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the treatment of topical inflammatory diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of topical inflammatory diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2052178

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.